Danisco

CompanyDenmark

Danisco develops 2 assets, the furthest in phase 3 (Menatetrenone in osteoporosis). Mostly supplement; based in Denmark.

2
Assets
Furthest stage
Phase 3
8
Trials
12
Signals

Pipeline

2
  • Menatetrenone

    Cofactor for gamma-glutamyl carboxylase essential for activating vitamin K-dependent proteins

    Phase 3, Supplement, osteoporosis, postmenopausal osteoporosis

  • (+)-epicatechin

    Flavanol that improves endothelial and vasodilatory function

    Phase 2, no development reported, Supplement, borderline hypertension, Becker muscular dystrophy (Phase 1)

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms4
  • Trials8
  • Signals20
  • Similar companies6

Intelligence